Selective Laser Trabeculoplasty (SLT) for Glaucoma
Understanding Glaucoma and How SLT Helps
Glaucoma is one of the leading causes of permanent vision loss, and controlling eye pressure is the foundation of its treatment. SLT offers a targeted, effective way to reduce that pressure and slow the disease before damage progresses.
Glaucoma is a group of eye diseases that damage the optic nerve, the structure that carries visual information from the eye to the brain. In most cases, this damage is driven by elevated intraocular pressure (IOP), the pressure of the fluid inside the eye. Vision loss from glaucoma typically begins at the edges of your sight and is irreversible, which is why early detection and treatment are so important.
SLT is a laser treatment that improves the eye's natural drainage system to reduce intraocular pressure. It delivers short, precise pulses of low-energy laser light to specific pigmented cells in the eye's drainage tissue, prompting the body to clear and refresh that tissue naturally. Because it targets only select cells, it leaves the surrounding structures unharmed and does not create scar tissue.
SLT can serve several roles in a glaucoma treatment plan. It may be recommended as a first-line treatment before starting eye drops, as a supplement when drops alone are not controlling pressure well enough, or as an alternative for patients who have difficulty with a daily drop routine. Your eye doctor will help determine the right role for SLT based on the type and severity of your glaucoma.
Yes. SLT has been FDA-approved for over two decades and has been performed on millions of patients worldwide. It evolved from an older laser treatment called Argon Laser Trabeculoplasty (ALT), but is gentler, creates less tissue disruption, and can be repeated if needed. It is now considered a standard, evidence-supported option in glaucoma care.
Who Is a Good Candidate for SLT?
SLT is a versatile treatment option, but it works best for specific types of glaucoma and elevated eye pressure. A thorough evaluation with your eye doctor will confirm whether SLT is the right fit for your situation.
Open-angle glaucoma is the most common form of the disease and the primary indication for SLT. In this type, the drainage canals of the eye gradually become less efficient, causing pressure to rise slowly over time. SLT directly targets this drainage system and is highly effective at improving outflow in these patients.
Ocular hypertension means your eye pressure is elevated above the normal range, but no optic nerve damage has occurred yet. For patients in this category, SLT may be offered as a preventive measure to reduce the risk of developing glaucoma. Lowering pressure early can significantly delay or prevent future damage.
Glaucoma eye drops must be used consistently and correctly every day to be effective. Some patients find this difficult due to side effects, cost, physical limitations, or simply the challenge of maintaining the routine. SLT is an excellent alternative or addition for these individuals, reducing or sometimes eliminating the need for daily drops.
SLT is not appropriate for every patient or every type of glaucoma. It is generally not recommended for those with angle-closure glaucoma (where the drainage angle is physically blocked), significant scarring in the drainage tissue, or active eye inflammation. Secondary glaucomas such as pigmentary or pseudoexfoliative glaucoma may still respond to SLT, but require careful evaluation. Your eye doctor will review your specific diagnosis before recommending this treatment.
How SLT Works to Lower Eye Pressure
SLT works by using the body's own healing response to restore more efficient drainage inside the eye. The process is gentle, precise, and does not require incisions or sedation.
The trabecular meshwork is the eye's primary drainage structure, a sponge-like tissue located at the base of the cornea. When this tissue becomes congested or less active, fluid builds up and pressure rises. Using a specialized contact lens placed on the surface of the eye, the laser is aimed directly at this drainage tissue to initiate improvement.
The laser selectively targets only the pigmented cells within the meshwork, leaving unpigmented cells and surrounding structures intact. This gentle stimulation activates the body's natural biological processes, encouraging the meshwork to function more efficiently and drain fluid more freely. Because no scar tissue forms, the treatment can be repeated in the future if needed.
Most patients experience a meaningful reduction in intraocular pressure following SLT. A drop of roughly 20 to 30 percent is typical, though individual results vary depending on starting pressure and the type of glaucoma. The full effect usually develops over one to three months, and your eye doctor will track your progress through follow-up visits.
What to Expect During the SLT Procedure
SLT is performed right in the office and takes only a short time from start to finish. Understanding each step of the process can help you feel prepared and at ease on the day of your appointment.
Your eye doctor will review your medical history, confirm your diagnosis, and explain the procedure in full before you begin. Numbing eye drops are placed in your eye to keep you comfortable throughout. You may also receive a drop beforehand to reduce the chance of a temporary pressure spike immediately after the laser is applied.
You will be seated at an instrument that looks similar to the slit lamp used during a routine eye exam. A small contact lens is gently placed on your eye to stabilize it and help focus the laser on the drainage tissue. The laser delivers a series of quick, quiet pulses of light. Most patients notice a brief flashing sensation and hear a soft clicking sound. The active treatment typically takes only five to ten minutes per eye.
Your eye pressure will be checked approximately one hour after the treatment to make sure there is no significant spike. Your vision may be mildly blurry for a few hours, so you will need to arrange for someone to drive you home. Your eye doctor will provide specific instructions to follow in the days after treatment.
- Use any prescribed anti-inflammatory eye drops as directed to manage mild post-treatment inflammation.
- Avoid rubbing the treated eye.
- Continue any glaucoma eye drops you are currently using unless your doctor tells you otherwise.
- Attend your scheduled follow-up appointment, typically within one to six weeks, to assess your eye pressure response.
Risks and Potential Side Effects of SLT
SLT has a strong safety record and serious complications are uncommon. As with any medical procedure, there are some possible side effects to be aware of, and your eye doctor will take steps to reduce your risk throughout the process.
The most frequently reported side effects are mild and short-lived. These include redness, light sensitivity, and a minor scratchy or gritty feeling in the treated eye. A brief, temporary rise in eye pressure immediately after the procedure can also occur. This is why your pressure is checked in the office before you leave, and why a preventive drop is often given beforehand.
In rare cases, some patients experience a more prolonged period of inflammation or a lasting increase in eye pressure that requires additional treatment. These situations are uncommon and can typically be managed effectively with medication. Serious or vision-threatening complications from SLT are very rare.
Careful candidate selection is one of the most important safety steps. Our team conducts a thorough diagnostic evaluation before recommending SLT, using tools such as tonometry to measure eye pressure, gonioscopy to examine the drainage angle, optical coherence tomography (OCT) to assess the optic nerve, and automated visual field testing to detect any loss of peripheral vision. Detailed pre- and post-treatment guidance, combined with consistent follow-up monitoring, helps ensure the safest possible outcome for each patient.
Frequently Asked Questions
If you are considering SLT, you likely have specific questions about how it fits your situation. The following answers are meant to help you make a confident, informed decision alongside your eye doctor.
No, and it is important to have realistic expectations. Glaucoma is a chronic condition with no cure. SLT is a pressure-management tool, not a permanent fix. It can significantly reduce eye pressure and help slow or halt optic nerve damage, but ongoing monitoring and potentially other treatments will still be part of your long-term care. Consistent follow-up with your eye doctor remains essential even after a successful SLT result.
This depends on how well your pressure responds and how much reduction is needed to protect your optic nerve. Some patients achieve enough pressure lowering with SLT alone that their eye doctor can reduce or eliminate certain drops. Others still require medication to maintain a safe pressure level. Do not stop any eye drops on your own. Your doctor will guide you through any medication changes based on your follow-up pressure readings.
The pressure-lowering benefit of SLT typically lasts between one and five years, though this varies from person to person. Because SLT does not cause scarring in the drainage tissue, the procedure can be safely repeated when the pressure-lowering effect begins to fade. This repeatability makes it a sustainable part of long-term glaucoma management for many patients.
SLT is considered a medically necessary procedure for glaucoma and ocular hypertension, and it is typically covered by Medicare and most major private insurance plans. Coverage details can vary, so it is a good idea to contact your insurance provider before your appointment to understand your specific benefits and any out-of-pocket costs you may be responsible for.
SLT does not produce a strong enough response in every patient, and that is not unusual. If your eye pressure does not reach a safe target level after treatment, your eye doctor will discuss additional options with you. These may include adjusting or adding eye drop medications, repeating SLT at a later date, or considering a surgical procedure such as Minimally Invasive Glaucoma Surgery (MIGS), trabeculectomy, or tube shunt surgery. A treatment plan for glaucoma is often adjusted over time to meet your changing needs.
Continue taking all of your current eye medications unless your doctor instructs otherwise. Plan to have a driver with you, since your vision may be temporarily blurry after the procedure and you should not drive that day. Wear comfortable clothing, bring any eyeglasses or contact lens information your doctor has requested, and set aside a couple of hours to allow time for pre-treatment preparation and post-treatment pressure monitoring before you leave the office.
Protecting Your Vision Starts Here
Our team at Rhode Island Eye Institute brings together fellowship-trained specialists, advanced diagnostics, and a genuine commitment to personalized care. Dr. Sarah Anis and our entire glaucoma team are here to help you understand your options and take confident steps to protect your sight. We invite you to schedule a consultation and experience the level of expertise and compassion that has earned us the trust of patients across Rhode Island and the surrounding region.